Fever in Young Infants: A Medicolegal Guide

Clinical Vignette

A 17-day-old infant is brought to an urgent care clinic with a rectal temperature of 38.4°C (101.1°F). The infant appears sleepy but feeds intermittently. The clinician documents that the baby "looks well" and reassures the parents that the illness is likely viral. No blood work, urinalysis, or cultures are obtained. No lumbar puncture is performed. The family is sent home without return precautions.

Overnight, the infant becomes progressively lethargic and develops mottled skin. By the time the parents arrive at the emergency department, the baby is in septic shock. Blood cultures grow Group B Streptococcus. Cerebrospinal fluid confirms bacterial meningitis. Despite aggressive treatment, the child survives with profound hearing loss and significant developmental delays.

Under the current standard of care, this infant — 17 days old with a documented fever — required a complete sepsis evaluation, parenteral antibiotics, and hospital admission, regardless of clinical appearance. The failure to perform this evaluation is one of the most clearly defined and frequently litigated deviations from the standard of care in pediatric medicine.

What Is Considered a Fever in a Young Infant?

In infants 60 days of age and younger, a fever is defined as a rectal temperature of 38.0°C (100.4°F) or higher. This is the only reliable method of temperature measurement in this age group. Axillary, temporal, and tympanic temperatures are not considered accurate in young infants and should not be used to exclude fever.

A single documented rectal temperature at or above this threshold triggers a specific, well-defined evaluation pathway. There is no "borderline" fever in a young infant — the threshold is absolute.

Why Young Infants Are Different

Fever in a young infant is treated fundamentally differently than fever in an older child or adult. There are several reasons:

• Immature immune system. Neonates and young infants have limited ability to mount an effective immune response. They rely heavily on maternal antibodies, which wane over the first weeks of life. Infections can progress rapidly from mild to life-threatening.
• Limited ability to localize infection. Unlike older children who develop focal signs — an ear infection, a sore throat, a cough — young infants with serious bacterial infections often present with nonspecific symptoms such as fussiness, poor feeding, or lethargy. Fever may be the only sign.
• Subtle clinical presentation. Many young infants with invasive bacterial infections — including bacteremia and meningitis — initially appear relatively well. Clinical appearance alone cannot reliably distinguish infants with serious bacterial infections from those with benign viral illnesses.
• Rapid deterioration. Young infants can progress from appearing well to septic shock within hours. The window for intervention is narrow, and delays in evaluation and treatment can result in permanent injury or death.

What Is Serious Bacterial Infection?

When clinicians evaluate a febrile young infant, they are primarily trying to identify or exclude serious bacterial infection (SBI). This term encompasses several distinct diagnoses:

• Urinary tract infection (UTI) — the most common SBI in febrile infants. Overall SBI prevalence in febrile infants 60 days and younger is approximately 8% to 13%, with UTIs representing the vast majority.
• Bacteremia — bacteria in the bloodstream. Prevalence is approximately 2% to 5% in the first month of life and approximately 1% to 2% in the second month.
• Bacterial meningitis — infection of the membranes surrounding the brain and spinal cord. Prevalence is approximately 0.5% to 1% in the first month and lower in the second month, but the consequences of a missed diagnosis are devastating.

Attorneys should also be aware of two additional infections that are critical in this age group:

• Herpes simplex virus (HSV) — a viral infection that can cause encephalitis, disseminated disease, and death in neonates. Population-based rates range from 2 to 5 per 100,000 live births, with 15% of affected infants presenting with fever as the only symptom. HSV must be considered in any febrile infant younger than 21 days, particularly those with vesicles, seizures, hypothermia, CSF pleocytosis, leukopenia, thrombocytopenia, elevated liver enzymes, or a maternal history of genital herpes. Delayed recognition and treatment of neonatal HSV is a well-recognized source of litigation.
• Sepsis — the systemic inflammatory response to infection, which can progress to septic shock, multiorgan failure, and death. A delay in antimicrobial therapy of more than 6 hours in bacterial meningitis has been associated with increased mortality from 6% to 45% and increased rates of neurological sequelae from 10% to 70%.

The Current Standard of Care: AAP 2021 Clinical Practice Guideline

In 2021, the American Academy of Pediatrics (AAP) published a landmark Clinical Practice Guideline for the evaluation and management of well-appearing febrile infants aged 8 to 60 days. This guideline, based on extensive evidence review and containing 21 key action statements, represents the most authoritative and widely adopted standard for managing febrile infants in the United States.

The guideline stratifies infants into three age groups, each with distinct evaluation and management recommendations.

Infants 8 to 21 Days Old

This is the highest-risk group. The AAP recommends:

• Complete blood count, blood culture, urinalysis, and urine culture
• Lumbar puncture with cerebrospinal fluid analysis and culture
• Parenteral (intravenous or intramuscular) antibiotics
• Hospital admission for monitoring

These recommendations apply to all well-appearing febrile infants in this age group, regardless of how well the infant appears. There is no low-risk pathway that permits discharge home for infants 21 days old or younger.

Infants 22 to 28 Days Old

The AAP recommends:

• Complete blood count, blood culture, urinalysis, and urine culture
• Inflammatory markers: procalcitonin (preferred), or C-reactive protein (CRP) and absolute neutrophil count (ANC) if procalcitonin is unavailable
• Lumbar puncture — recommended, though in some circumstances clinicians may elect to defer
• Parenteral antibiotics
• Hospital admission

Inflammatory markers help guide ongoing management but do not eliminate the need for cultures, antibiotics, and hospitalization in this age group.

Infants 29 to 60 Days Old

The AAP recommends:

• Complete blood count, blood culture, urinalysis, and urine culture
• Inflammatory markers

For infants in this age group, the results of inflammatory markers determine the next steps:

• Normal inflammatory markers: Lumbar puncture may be deferred. The infant may be managed at home if specific safety criteria are met, including reliable follow-up within 24 hours, reliable communication, and parental agreement.
• Abnormal inflammatory markers: Lumbar puncture, parenteral antibiotics, and hospital admission are recommended.

Inflammatory markers are considered abnormal at the following thresholds: procalcitonin greater than 0.5 ng/mL, CRP greater than 20 mg/L, ANC greater than 4,000 to 5,200/mm³, or temperature greater than 38.5°C.

Important Caveats

The AAP guideline applies to well-appearing, previously healthy, full-term infants. It excludes infants who appear ill, were born prematurely, have congenital abnormalities, are immunocompromised, or received immunizations within the prior 24 hours. Any infant who appears ill — regardless of age — requires immediate full evaluation and treatment.

The guideline itself states that its recommendations "do not indicate an exclusive course of treatment or serve as a standard of medical care" and that "variations, taking into account individual circumstances, may be appropriate." However, in practice, these recommendations are widely regarded as defining the expected standard of care, and significant deviations — particularly the failure to perform any evaluation in a febrile neonate — are difficult to defend.

Common Allegations in Litigation

Febrile infant cases in litigation typically involve one or more of the following allegations:

• Failure to recognize fever. Temperature was not taken, was taken by an unreliable method (e.g., axillary or temporal), or a documented fever was not acted upon.
• Failure to obtain appropriate laboratory studies. No blood work, urinalysis, or cultures were obtained despite a documented fever in a young infant.
• Failure to perform lumbar puncture. In infants 21 days old or younger, lumbar puncture is recommended for all febrile infants. Failure to obtain CSF — or failure to consider HSV testing when risk factors are present — may constitute a deviation from the standard of care.
• Failure to follow age-based evaluation pathways. The AAP guideline provides clear, age-stratified algorithms. Treating a 14-day-old febrile infant the same as a 6-month-old with fever represents a fundamental failure to apply the appropriate standard.
• Failure to hospitalize. Infants 28 days old or younger with fever require hospitalization. Discharging a febrile neonate from an emergency department or urgent care without evaluation and admission is one of the most clearly indefensible deviations from the standard of care.
• Failure to administer timely antibiotics. Once the decision is made to treat, delays in antibiotic administration can directly contribute to adverse outcomes. In bacterial meningitis, delays beyond 6 hours are associated with dramatically increased mortality and morbidity.
• Failure to reassess. An infant who is evaluated and initially appears well may deteriorate. Failure to reassess vital signs, clinical status, and pending laboratory results can result in missed opportunities for intervention.
• Inadequate discharge instructions. When an older febrile infant (29–60 days) is managed at home based on normal inflammatory markers, clear return precautions must be provided and documented. Failure to communicate specific warning signs — and to document that communication — is a common allegation.

Medical Causation

Causation is often the most contested element in febrile infant litigation. The central question is: would earlier evaluation and treatment have changed the outcome? Key causation considerations include:

• Timing of antibiotic administration. For bacterial meningitis, evidence demonstrates that delays in antibiotic therapy are associated with increased mortality and neurological sequelae. If a delay in evaluation directly delayed antibiotic administration, and the infant subsequently developed meningitis complications, a causal link may be established.
• Progression from bacteremia to meningitis. Bacteremia can progress to meningitis if untreated. If blood cultures would have been positive and prompted treatment before meningitis developed, the failure to obtain cultures may be causally linked to the meningitis and its consequences.
• HSV encephalitis. Neonatal HSV encephalitis carries high mortality and morbidity. Delayed initiation of acyclovir is associated with worse outcomes. If HSV risk factors were present and not recognized, the delay in treatment may be causally related to neurological injury.
• Natural history of disease. Not every adverse outcome is preventable. Some infants with bacterial meningitis develop complications despite timely and appropriate treatment. Expert review is essential to determine whether the outcome was related to the alleged delay or to the inherent severity of the infection.
• Intervening factors. Causation analysis must also consider whether other factors — such as the virulence of the organism, the infant's underlying health, or complications of treatment itself — contributed to the outcome independently of any alleged delay.

Neurodevelopmental Consequences and Damages

The consequences of missed or delayed diagnosis of serious bacterial infection in young infants can be severe and lifelong.

Bacterial Meningitis Outcomes

Bacterial meningitis in neonates carries a case fatality rate of approximately 10% in high-income countries. Among survivors, approximately 50% develop neurological sequelae, including:

• Hearing loss — the most common long-term complication, occurring in up to 30% of survivors. A recent study of neonatal meningitis complicated by hydrocephalus found hearing impairment in 53% of affected infants.
• Cognitive impairment and intellectual disability — early-onset neonatal meningitis is associated with a nearly 8-fold increased risk of intellectual disability and a 3-fold increased risk of requiring special educational services.
• Cerebral palsy — neonatal sepsis is associated with a 2.5-fold increased risk of cerebral palsy.
• Seizure disorders and epilepsy.
• Hydrocephalus — requiring surgical intervention.
• Visual impairment — neonatal sepsis is associated with a 2.6-fold increased risk of visual impairment.
• Behavioral and emotional disorders.

These disabilities persist into adulthood. A Swedish nationwide study following children with bacterial meningitis for up to 30 years found sustained and significantly elevated risks of hearing loss, visual disturbances, behavioral disorders, and intracranial structural injuries compared with matched controls.

Neonatal Sepsis Outcomes

Even without meningitis, neonatal sepsis is independently associated with adverse neurodevelopmental outcomes. Early-onset neonatal sepsis is associated with a 2.2-fold increased risk of intellectual disability and a 1.5-fold increased risk of special educational needs.

Damages Categories

Damages in febrile infant cases may include:

• Lifelong medical costs — neurology, audiology, rehabilitation, and specialty follow-up.
• Hearing aids, cochlear implants, and related services.
• Special education and developmental services — speech therapy, occupational therapy, physical therapy, behavioral health.
• Reduced earning capacity — related to cognitive, sensory, or motor impairments.
• Pain and suffering — including the burden of repeated hospitalizations, procedures, and chronic disability.
• Wrongful death — in cases where delayed treatment results in mortality.
• Loss of parental consortium — the impact on the parent-child relationship.

Common Misconceptions

• "The infant looked well." This is perhaps the most dangerous misconception — and the most common defense. Many young infants with invasive bacterial infections initially appear well. The AAP guideline explicitly addresses well-appearing infants because clinical appearance alone is insufficient to exclude serious infection. Approximately 4% of febrile infants 28 days or younger harbor invasive bacterial infections, and many appear well at presentation.
• "The fever was low-grade." Any rectal temperature of 38.0°C or higher in an infant 60 days old or younger meets the threshold for evaluation. There is no "low-grade fever" exception in this age group.
• "The fever was probably from the vaccines." The AAP guideline specifically excludes infants who received immunizations within the prior 24 hours. However, routine immunizations are not administered before 2 months of age. A fever in an infant younger than 8 weeks cannot be attributed to vaccines.
• "A positive viral test rules out bacterial infection." False. While identification of a viral pathogen may modify the evaluation in some clinical contexts, viral and bacterial infections can coexist. A positive viral test does not eliminate the need for bacterial cultures and appropriate evaluation, particularly in the youngest infants.
• "The parents were told to come back if the baby got worse." Verbal reassurance without documented, specific return precautions does not meet the standard of care. Moreover, for infants 28 days old or younger, discharge home without evaluation is itself the deviation — return precautions do not substitute for the required workup.

Medical Records That Often Matter

Thorough case evaluation in febrile infant litigation depends on reviewing:

• Nursing notes and vital signs — including the exact temperature, method of measurement, and time recorded. Nursing documentation of clinical appearance, feeding, and activity level is often more detailed than physician notes and may reveal observations that were not acted upon.
• Temperature documentation — was a rectal temperature obtained? If an alternative method was used, was a rectal temperature subsequently confirmed?
• Urine collection method — a bag specimen is not adequate for culture. Catheterized or suprapubic specimens are required for reliable results.
• Blood and urine culture results — including the time cultures were obtained relative to the time of presentation and the time antibiotics were administered.
• Lumbar puncture results — CSF cell count, protein, glucose, Gram stain, bacterial culture, and viral PCR results. If lumbar puncture was not performed, the documentation should reflect the clinical reasoning.
• Timing of antibiotic administration — the interval between presentation, evaluation, and first dose of antibiotics is often a critical element in causation analysis.
• Discharge instructions — were specific return precautions documented? Were they provided in writing? Were they provided in the family's primary language?
• Follow-up documentation — was a follow-up visit arranged within 24 hours for infants managed at home? Was it completed?

The Value of Pediatric Expertise

The evaluation of fever in young infants is governed by pediatric-specific guidelines that differ fundamentally from adult emergency medicine practice. A febrile 3-week-old infant is not a small adult — the differential diagnosis, evaluation pathway, risk stratification, and management are entirely different.

Attorneys handling febrile infant cases should be aware that:

• General emergency medicine experts may not be familiar with the nuances of the AAP febrile infant guideline or the age-specific risk stratification that drives management decisions.
• Pediatric-specific expertise is essential for evaluating whether the standard of care was met, particularly regarding the decision to perform or defer lumbar puncture, the interpretation of inflammatory markers, and the appropriateness of disposition.
• Causation analysis requires understanding the natural history of neonatal bacterial infections, the expected response to timely treatment, and the known outcomes of delayed diagnosis.

An experienced pediatric expert can assist attorneys by interpreting the medical record in the context of current evidence-based guidelines, identifying deviations from the standard of care, evaluating causation, and explaining complex medical concepts in language accessible to judges and juries.

Key Takeaways for Attorneys

1. Any rectal temperature of 38.0°C (100.4°F) or higher in an infant 60 days old or younger triggers a defined evaluation pathway. There is no clinical judgment exception for the youngest infants — the evaluation is required.
2. Infants 21 days old or younger with fever require a complete sepsis workup, parenteral antibiotics, and hospitalization — without exception. This is the clearest and most defensible standard in pediatric emergency care.
3. "The baby looked well" is not a defense. The AAP guideline was specifically designed for well-appearing infants because clinical appearance alone cannot exclude serious bacterial infection.
4. Timing matters. Delays in antibiotic administration — particularly in bacterial meningitis — are directly associated with increased mortality and permanent neurological injury.
5. The consequences of a missed diagnosis can be catastrophic and lifelong. Hearing loss, intellectual disability, cerebral palsy, seizure disorders, and death are all well-documented outcomes of delayed treatment of neonatal bacterial infections.

This article is provided for educational purposes only and does not constitute legal or medical advice. Every case is unique and should be evaluated on its individual facts and medical records. Reading this article does not create an expert-client relationship.